Barclays’s Trueblue TBI Stock Holding History

Barclays’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,000	Closed	-$22K	–	7115
2019 Q2	$22K	Hold	1,000	–	–	﹤0.01%	6398
2019 Q1	$24K	Buy	+1,000	New	+$23.4K	﹤0.01%	6284

Other funds holding TBI

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IES Holdings Houston, Texas $311M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ACM

Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's TBI Position: Q2 2026 in Review

Barclays reduced its Trueblue (TBI) stake by 1.1% in Q2 2026, selling an estimated $2.71K and leaving 43,883 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #3489.

Barclays first reported a position in TBI in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.33M in Q1 2018. 113 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

Barclays held 43,883 shares of Trueblue worth $306K as of Q2 2026.
Barclays sold 486 Trueblue shares in Q2 2026, an estimated $2.71K.
Trueblue made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3489 holding.
Barclays first reported a position in Trueblue in Q2 2013 and has held it in 53 quarters since.
Barclays's Trueblue position peaked at $2.33M in Q1 2018.
113 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.